3 ms·
Please note that patents are not considered by the FDA as an compensation method in regard to investment in clinical trials. For clinical trials, FDA gives out
by belorn 14y ago
Please note that patents are not considered by the FDA as an compensation method in regard to investment in clinical trials. For clinical trials, FDA gives out a special monopole status to encourage further trials to be made. In this case, Tecfidera got exclusivity power in the market from both the FDA and the patent office.